Page last updated: 2024-11-02

piribedil and Drooling

piribedil has been researched along with Drooling in 1 studies

Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.

Research Excerpts

ExcerptRelevanceReference
"The inclusion of piribedil (150-250 mg/day) in the 6-months therapy reduces the dysfunction of the upper gastrointestinal tract (by 61 and 74% of the initial level of dysphagia and sialorrhea, respectively) regardless the drug use in monotherapy or in complex therapy with levodopa."4.12[Upper gastrointestinal tract dysfunction and its correction by dopamine agonists for patients with Parkinson's disease of I-III stage]. ( Pilipovich, AA; Vorob'eva, OV, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Pilipovich, AA3
Vorob'eva, OV3

Other Studies

1 other study available for piribedil and Drooling

ArticleYear
[Upper gastrointestinal tract dysfunction and its correction by dopamine agonists for patients with Parkinson's disease of I-III stage].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2022, Volume: 122, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Deglutition Disorders; Dopamine Agonists; Female; Gastrointestinal D

2022
[Upper gastrointestinal tract dysfunction and its correction by dopamine agonists for patients with Parkinson's disease of I-III stage].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2022, Volume: 122, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Deglutition Disorders; Dopamine Agonists; Female; Gastrointestinal D

2022
[Upper gastrointestinal tract dysfunction and its correction by dopamine agonists for patients with Parkinson's disease of I-III stage].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2022, Volume: 122, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Deglutition Disorders; Dopamine Agonists; Female; Gastrointestinal D

2022
[Upper gastrointestinal tract dysfunction and its correction by dopamine agonists for patients with Parkinson's disease of I-III stage].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2022, Volume: 122, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Deglutition Disorders; Dopamine Agonists; Female; Gastrointestinal D

2022